Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection.
Autor: | Gowdy KM; Duke University Medical Center, Durham, NC, 27710, United States. Electronic address: kymberly.gowdy@nih.gov., Martinu T; Duke University Medical Center, Durham, NC, 27710, United States., Nugent JL; Duke University Medical Center, Durham, NC, 27710, United States., Manzo ND; Duke University Medical Center, Durham, NC, 27710, United States., Zhang HL; Duke University Medical Center, Durham, NC, 27710, United States., Kelly FL; Duke University Medical Center, Durham, NC, 27710, United States., Holtzman MJ; Washington University School of Medicine, St. Louis, MO, 63110, United States., Palmer SM; Duke University Medical Center, Durham, NC, 27710, United States; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Transplant immunology [Transpl Immunol] 2015 Jan; Vol. 32 (1), pp. 51-60. Date of Electronic Publication: 2014 Nov 05. |
DOI: | 10.1016/j.trim.2014.10.005 |
Abstrakt: | Rationale: Bone marrow transplant (BMT) recipients experience frequent and severe respiratory viral infections (RVIs). However, the immunological mechanisms predisposing to RVIs are uncertain. Therefore, we hypothesized that antiviral T cell immunity is impaired as a consequence of allogeneic BMT, independent of pharmacologic immunosuppression, and is responsible for increased susceptibility to RVI. Methods: Bone marrow and splenocytes from C57BL/6(H2(b)) mice were transplanted into B10.BR(H2(k)) (Allo) or C57BL/6(H2(b)) (Syn) recipients. Five weeks after transplantation, recipient mice were inoculated intranasally with mouse parainfluenza virus type 1 (mPIV-1), commonly known as Sendai virus (SeV), and monitored for relevant immunological and disease endpoints. Main Results: Severe and persistent airway inflammation, epithelial injury, and enhanced mortality are found after viral infection in Allo mice but not in control Syn and non-transplanted mice. In addition, viral clearance is delayed in Allo mice as evidenced by prolonged detection of viral transcripts at Day 15 post-inoculation (p.i.) but not in control mice. In concert with these events, we also detected decreased levels of total and virus-specific CD8(+) T cells, as well as increased T cellexpression of inhibitory receptor programmed death-1 (PD-1), in the lungs of Allo mice at Day 8 p.i. Adoptive transfer of CD8(+) T cells from non-transplanted mice recovered from SeV infection into Allo mice at Day 8 p.i. restored normal levels of viral clearance, epithelial repair, and lung inflammation. Conclusions: Taken together these results indicate that allogeneic BMT results in more severe RVI based on the failure to develop an appropriate pulmonary CD8(+) T cell response, providing an important potential mechanism to target in improving outcomes of RVI after BMT. (Published by Elsevier B.V.) |
Databáze: | MEDLINE |
Externí odkaz: |